ストックスクリーナーアプリを入手
11.85
1.09%
-0.12
前日終値:
$11.97
開ける：
$11.97
24時間の取引高:
569.25K
Relative Volume:
0.38
時価総額：
$658.70M
収益：
$312.78M
当期純損益:
$-143.56M
株価収益率:
-4.4052
EPS:
-2.69
ネットキャッシュフロー:
$1.22M
1週間 パフォーマンス:
-6.03%
1か月 パフォーマンス:
-41.18%
6か月 パフォーマンス:
-48.09%
1年 パフォーマンス:
-56.20%
1日の値動き範囲:
$11.83
$12.19
1週間の範囲:
$11.26
$13.28
52週間の値動き範囲:
$10.96
$34.84
Caredx Inc Stock (CDNA) Company Profile
CDNA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
11.83 | 697.27M | 312.78M | -143.56M | 1.22M | -2.69 |
|
TMO
Thermo Fisher Scientific Inc
|
462.29 | 169.53B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
199.88 | 139.75B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
651.56 | 49.94B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
114.39 | 32.16B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
179.91 | 30.17B | 15.50B | 1.33B | 2.16B | 7.34 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-15 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2024-08-28 | 開始されました | Wells Fargo | Underweight |
| 2024-08-19 | アップグレード | BTIG Research | Neutral → Buy |
| 2024-05-13 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2024-05-01 | アップグレード | Craig Hallum | Hold → Buy |
| 2023-11-09 | アップグレード | Stephens | Equal-Weight → Overweight |
| 2023-08-15 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2023-05-11 | ダウングレード | BTIG Research | Buy → Neutral |
| 2023-03-07 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2023-03-03 | ダウングレード | Craig Hallum | Buy → Hold |
| 2023-03-03 | ダウングレード | Raymond James | Strong Buy → Mkt Perform |
| 2022-04-25 | 開始されました | Stephens | Overweight |
| 2021-07-20 | 再開されました | BTIG Research | Buy |
| 2021-06-03 | 開始されました | Goldman | Buy |
| 2021-02-26 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2020-10-30 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-10-08 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-10-02 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-08-05 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-06-26 | 開始されました | BTIG Research | Buy |
| 2020-06-19 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-10-01 | 再開されました | Craig Hallum | Buy |
| 2019-05-09 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2019-02-15 | 開始されました | Jefferies | Buy |
| 2018-10-23 | 再開されました | Raymond James | Strong Buy |
| 2018-09-18 | 繰り返されました | H.C. Wainwright | Neutral |
| 2017-11-27 | 開始されました | H.C. Wainwright | Buy |
| 2016-06-14 | 繰り返されました | Mizuho | Buy |
| 2015-09-29 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2015-09-25 | 開始されました | Craig Hallum | Buy |
| 2015-03-18 | 繰り返されました | Mizuho | Buy |
すべてを表示
Caredx Inc (CDNA) 最新ニュース
CareDx Reports Strong Growth in Testing Services - MSN
CareDx, Inc (NASDAQ:CDNA) Q2 2025 Earnings Call Transcript - Insider Monkey
CareDx Q2 2025 slides: 14% revenue growth despite analyst miss, EBITDA surges - Investing.com
How CareDx Inc stock performs during market volatility300% Return Stock Forecast - classian.co.kr
CareDx Publishes KOAR Study In American Journal of Transplantation, Showcasing AlloSure Dd-cfDNA For Enhanced Kidney Rejection Detection And Biopsy Guidance - 富途牛牛
CareDx Inc. Reports Strong Growth Amid Challenges - TipRanks
CareDx secretary Novack sells $34,380 in shares - Investing.com
CareDx secretary Novack sells $34,380 in shares By Investing.com - Investing.com Canada
CareDx Appoints New CFO Amid Financial Growth - MSN
CareDx Faces Financial Challenges Amid Mixed Signals and Policy Uncertainties - TipRanks
CareDx 2025 Q2 Earnings EPS Beats Expectations, Net Loss Widens - AInvest
CareDx narrows 2025 revenue guidance to $367M-$373M as kidney surveillance protocols expand - MSN
CareDx Names Nathan Smith as Chief Financial Officer - MarketScreener
CareDx (CDNA) EPS Beats Sales Gain 14% - sharewise.com
Earnings call transcript: CareDx Q2 2025 misses revenue forecasts By Investing.com - Investing.com South Africa
Earnings call transcript: CareDx Q2 2025 misses revenue forecasts - Investing.com
CareDx Publishes Landmark KOAR Study on AlloSure Efficacy in Kidney Transplant Surveillance in American Journal of Transplantation. - AInvest
CareDx Announces Appointment of Nathan Smith as Chief Financial Officer - BioSpace
CareDx Names Nathan Smith as New CFO - AInvest
Here's What Key Metrics Tell Us About CareDx (CDNA) Q2 Earnings - Yahoo Finance
CareDx (CDNA) Lags Q2 Earnings and Revenue Estimates - Nasdaq
CareDx: Q2 Earnings Snapshot - San Antonio Express-News
CareDx Inc. Faces Q2 Loss with Revenue Below ExpectationsNews and Statistics - IndexBox
CareDx's Strategic Leadership Shift: How CFO Nathan Smith's Appointment Signals a New Era of Growth - AInvest
Caredx Inc earnings beat by $0.20, revenue fell short of estimates - Investing.com South Africa
CareDx narrows FY25 revenue view to $367M-$373M from $365M-$375M - TipRanks
CareDx Q2 Testing Volume Surges 20%, Narrows 2025 Revenue Outlook | CDNA Stock News - Stock Titan
CareDx Announces Landmark KOAR Study Published in the American Journal of Transplantation - Lelezard
AlloSure kidney transplant test shows strong predictive value for rejection By Investing.com - Investing.com Nigeria
Pinnacle West Q2 Earnings In Line With Estimates, Revenues Rise Y/Y - The Globe and Mail
CareDx ($CDNA) Is Paying a $20.25M Settlement to Investors — Here’s How to Get Your Share - TradingView
What are the technical indicators suggesting about CareDx IncFree Stock Market Return Analysis - Jammu Links News
What are the latest earnings results for CareDx IncGet alerts on high-potential stock breakouts - Jammu Links News
When is CareDx Inc stock expected to show significant growthStrong return on investment - Jammu Links News
Does CareDx Inc stock perform well during market downturnsDiscover dynamic stocks ready to soar - Jammu Links News
How does CareDx Inc compare to its industry peersAchieve consistent profits with disciplined trading - Jammu Links News
Is CareDx Inc stock overvalued or undervaluedExceptional portfolio growth - Jammu Links News
Should I hold or sell CareDx Inc stock in 2025Invest smarter with advanced market data - Jammu Links News
Why is CareDx Inc stock attracting strong analyst attentionStrongest growth potential - Jammu Links News
How volatile is CareDx Inc stock compared to the marketMaximize your returns with expert insights - Jammu Links News
What analysts say about CareDx Inc stockMaximize gains with data-driven trading alerts - Jammu Links News
What is the dividend policy of CareDx Inc stockFree Stock Market Return Analysis - Jammu Links News
What institutional investors are buying CareDx Inc stockTremendous financial leverage - Jammu Links News
Is CareDx Inc a growth stock or a value stockAchieve rapid financial growth with expert picks - Jammu Links News
No Bull | The Five Spot - The Globe and Mail
CareDx’s ALAMO Study: Advancing Lung Transplant Surveillance - TipRanks
CareDx’s HeartCare Study: A Game Changer in Heart Transplant Monitoring? - TipRanks
Caredx Inc (CDNA) 財務データ
収益
当期純利益
現金流量
EPS
0.09%
0.65%
大文字化:
|
ボリューム (24 時間):